c11orf95-rela fusions drive oncogenic nf-kappa b signalling ependymoma 
members nuclear factor-kappa b nf-kappa b family transcriptional regulators central mediators cellular inflammatory response although constitutive nf-kappa b signalling present human tumours mutations pathway members rare complicating efforts understand block aberrant nf-kappa b activity cancer show two-thirds supratentorial ependymomas contain oncogenic fusions rela principal effector canonical nf-kappa b signalling uncharacterized gene c11orf95 case c11orf95-rela fusions resulted chromothripsis involving chromosome 11q131 c11orf95-rela fusion proteins translocated spontaneously nucleus activate nf-kappa b target genes rapidly transformed neural stem cells-the cell origin ependymoma-to form tumours mice data identify highly recurrent genetic alteration rela human cancer c11orf95-rela fusion protein potential therapeutic target supratentorial ependymoma 
